Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 281510, 9 pages
http://dx.doi.org/10.1155/2014/281510
Clinical Study

Improvement of Oxidative and Metabolic Parameters by Cellfood Administration in Patients Affected by Neurodegenerative Diseases on Chelation Treatment

1Department of Biomedical Sciences for Health, University of Milan, Via L. Mangiagalli 31, 20133 Milan, Italy
2Department of Biomedical, Surgical and Dental Sciences, University of Milan and Haematology-Oncology and BMT Unit, IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via F. Sforza 33, 20122 Milan, Italy

Received 9 May 2014; Revised 20 June 2014; Accepted 23 June 2014; Published 10 July 2014

Academic Editor: Amit K. Srivastava

Copyright © 2014 Alessandro Fulgenzi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. von Geldern and E. M. Mowry, “The influence of nutritional factors on the prognosis of multiple sclerosis,” Nature Reviews Neurology, vol. 8, no. 12, pp. 678–689, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. N. Limousin, H. Blasco, P. Corcia et al., “Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS,” Journal of the Neurological Sciences, vol. 297, no. 1-2, pp. 36–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. W. Mi, N. van Wijk, M. Cansev, J. W. C. Sijben, and P. J. G. H. Kamphuis, “Nutritional approaches in the risk reduction and management of Alzheimer's disease,” Nutrition, vol. 29, no. 9, pp. 1080–1089, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Guerra-Araiza, A. L. Álvarez-Mejía, S. Sánchez-Torres et al., “Effect of natural exogenous antioxidants on aging and on neurodegenerative diseases,” Free Radical Research, vol. 47, no. 6-7, pp. 451–462, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Kouti, M. Noroozian, S. Akhondzadeh et al., “Nitric oxide and peroxynitrite serum levels in Parkinson's disease: correlastion of oxidative stress and the severity of the disease,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 7, pp. 964–970, 2013. View at Google Scholar · View at Scopus
  6. F. Ferreres, C. Grosso, A. Gil-Izquierdo, P. Valentão, and P. B. Andrade, “Phenolic compounds from Jacaranda caroba (Vell.) A. DC.: approaches to neurodegenerative disorders,” Food and Chemical Toxicology, vol. 57, pp. 91–98, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. M. J. Holmay, M. Terpstra, L. D. Coles et al., “N-acetylcysteine boosts brain and blood glutathione in gaucher and Parkinson diseases,” Clinical Neuropharmacology, vol. 36, no. 4, pp. 103–106, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Kasote, M. V. Hegde, and S. S. Katyare, “Mitochondrial dysfunction in psychiatric and neurological diseases: cause(s), consequence(s), and implications of antioxidant therapy,” BioFactors, vol. 39, no. 4, pp. 392–406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Edeas and V. Weissig, “Targeting mitochondria: strategies, innovations and challenges: the future of medicine will come through mitochondria,” Mitochondrion, vol. 13, no. 5, pp. 389–390, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Mao, M. Manczak, U. P. Shirendeb, and P. H. Reddy, “MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis,” Biochimica et Biophysica Acta, vol. 1832, no. 12, pp. 2322–2331, 2013. View at Publisher · View at Google Scholar
  11. E. Ferrero, A. Fulgenzi, D. Belloni, C. Foglieni, and M. E. Ferrero, “Cellfood improves respiratory metabolism of endothelial cells and inhibits hypoxia-induced rective oxygen species (ROS) generation,” Journal of Physiology and Pharmacology, vol. 62, no. 3, pp. 287–293, 2011. View at Google Scholar · View at Scopus
  12. A. Fulgenzi, S. G. Zanella, M. M. Mariani, D. Vietti, and M. E. Ferrero, “A case of multiple sclerosis improvement following removal of heavy metal intoxication,” BioMetals, vol. 25, no. 3, pp. 569–576, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. D. T. Lin-Tan, J. L. Lin, T. H. Yen, K. H. Chen, and Y. L. Huang, “Long-term outcome of repeated lead chelation therapy in progressive non-diabetic chronic kidney diseases,” Nephrology Dialysis Transplantation, vol. 22, no. 10, pp. 2924–2931, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Lin, D. Lin-Tan, K. Hsu, and C. Yu, “Environmental lead exposure and progression of chronic renal diseases in patients without diabetes,” The New England Journal of Medicine, vol. 348, no. 4, pp. 277–286, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, “Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options,” Current Neuropharmacology, vol. 7, no. 1, pp. 65–74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. E. Presnell, G. Bhatti, L. S. Numan et al., “Computational insights into the role of glutathione in oxidative stress,” Current Neurovascular Research, vol. 10, no. 2, pp. 185–194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. C. O'Sullivan and K. K. Dev, “The structure and function of the S1P1 receptor,” Trends in Pharmacological Sciences, vol. 34, no. 7, pp. 401–412, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Chiba and K. Adachi, “Discovery of fingolimod, the sphingosine 1-phosphate receptor modulator and its application for the therapy of multiple sclerosis,” Future Medicinal Chemistry, vol. 4, no. 6, pp. 771–781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. Roussel, I. Hininger-Favier, R. S. Waters, M. Osman, K. Fernholz, and R. A. Anderson, “EDTA chelation therapy, without added vitamin C, decreases oxidative DNA damage and lipid peroxidation,” Alternative Medicine Review, vol. 14, no. 1, pp. 56–61, 2009. View at Google Scholar · View at Scopus
  20. S. Benedetti, S. Catalani, F. Palma, and F. Canestrari, “The antioxidant protection of CELLFOOD against oxidative damage in vitro,” Food and Chemical Toxicology, vol. 49, no. 9, pp. 2292–2298, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Pawlak, M. Mysliwiec, and D. Pawlak, “Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio—are they real oxidative stress markers in dialyzed patients?” Life Sciences, vol. 92, no. 4-5, pp. 253–258, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Millan, X. Pinto, A. Munoz, M. Zuniga, J. Rubies-Prat, L. F. Pallardo et al., “Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention,” Vascular Health and Risk Management, vol. 5, pp. 757–765, 2009. View at Google Scholar
  23. P. Kovacic and R. Somanathan, “Redox processes in neurodegenerative disease involving reactive oxygen species,” Current Neuropharmacology, vol. 10, no. 4, pp. 289–302, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Das, E. Bhaumik, U. Raychaudhuri, and R. Chakraborty, “Role of nutraceuticals in human health,” Journal of Food Science and Technology, vol. 49, no. 2, pp. 173–183, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Soory, “Nutritional antioxidants and their applications in cardiometabolic diseases,” Infectious Disorders—Drug Targets, vol. 12, no. 5, pp. 388–401, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. M. Alvarez-Suarez, F. Giampieri, and M. Battino, “Honey as a source of dietary antioxidants: structures, bioavailability and evidence of protective effects against human chronic diseases,” Current Medicinal Chemistry, vol. 20, no. 5, pp. 621–638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Patrick, “Toxic metals and antioxidants: part II. The role of antioxidants in arsenic and cadmium toxicity,” Alternative Medicine Review, vol. 8, no. 2, pp. 106–128, 2003. View at Google Scholar · View at Scopus
  28. S. De Nicoló, L. Tarani, M. Ceccanti et al., “Effects of olive polyphenols administration on nerve growth factor and brain-derived neurotrophic factor in the mouse brain,” Nutrition, vol. 29, no. 4, pp. 681–687, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. D. P. de Araújo, C. N. De Sousa, P. V. P. Araújo et al., “Behavioral and neurochemical effects of alpha-lipoic Acid in the model of Parkinson's disease induced by unilateral stereotaxic injection of 6-ohda in rat,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 571378, 13 pages, 2013. View at Publisher · View at Google Scholar
  30. I. Cacciatore, C. Cornacchia, E. Fornasari et al., “A glutathione derivative with chelating and in vitro neuroprotective activities: synthesis, physicochemical properties, and biological evaluation,” ChemMedChem, vol. 8, no. 11, pp. 1818–1829, 2013. View at Publisher · View at Google Scholar
  31. R. Goldschmidt, P. M. Arce, O. M. Khdour et al., “Effects of cytoprotective antioxidants on lymphocytes from representative mitochondrial neurodegenerative diseases,” Bioorganic and Medicinal Chemistry, vol. 21, no. 4, pp. 969–978, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Csont, M. Sarkozy, G. Szucs, C. Szucs, J. Barkanyi, and P. Bencsik, “Effect of a multivitamin preparation supplemented with phytosterol on serum lipids and infarct size in rats fed with normal and high cholesterol diet,” Lipids in Health and Disease, vol. 12, p. 138, 2013. View at Publisher · View at Google Scholar
  33. M. C. Pantzaris, G. N. Loukaides, E. E. Ntzani, and I. S. Patrikios, “A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial,” BMJ Open, vol. 3, no. 4, Article ID e002170, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Jin, A. Kanthasamy, A. Ghosh, V. Anantharam, B. Kalyanaraman, and A. G. Kanthasamy, “Mitochondria-targeted antioxidants for treatment of Parkinson's disease: preclinical and clinical outcomes,” Biochimica et Biophysica Acta, vol. 1842, no. 8, pp. 1282–1294, 2014. View at Google Scholar
  35. J. de Oliveira, M. A. Hort, E. L. G. Moreira et al., “Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress,” Neuroscience, vol. 197, pp. 99–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Palavra, D. Marado, F. Mascarenhas-Melo et al., “New markers of early cardiovascular risk in multiple sclerosis patients: oxidized-LDL correlates with clinical staging,” Disease Markers, vol. 34, no. 5, pp. 341–348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Kardys, B. Weinstock-Guttman, M. Dillon et al., “Cholesterol affects retinal nerve fiber layer thickness in patients with multiple sclerosis with optic neuritis,” European Journal of Neurology, vol. 20, no. 9, pp. 1264–1271, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Weinstock-Guttman, R. Zivadinov, D. Horakova et al., “Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, pp. 1186–1191, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Murri, M. Luque-Ramírez, M. Insenser, M. Ojeda-Ojeda, and H. F. Escobar-Morreale, “Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis,” Human Reproduction Update, vol. 19, no. 3, pp. 268–288, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. B. Kalyanaraman, “Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms,” Redox Biology, vol. 1, no. 1, pp. 244–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Refsum, A. D. Smith, P. M. Ueland et al., “Facts and recommendations about total homocysteine determinations: an expert opinion,” Clinical Chemistry, vol. 50, no. 1, pp. 3–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Bamonti, G. A. Moscato, C. Novembrino et al., “Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory,” Clinical Chemistry and Laboratory Medicine, vol. 48, no. 2, pp. 249–253, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. K. D. Jacob, N. N. Hooten, A. R. Trzeciak, and M. K. Evans, “Markers of oxidant stress that are clinically relevant in aging and age-related disease,” Mechanisms of Ageing and Development, vol. 134, no. 3-4, pp. 139–157, 2013. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Aoyama and T. Nakaki, “Impaired glutathione synthesis in neurodegeneration,” International Journal of Molecular Sciences, vol. 14, pp. 21021–21044, 2013. View at Google Scholar
  45. R. Rossi, I. Dalle-Donne, A. Milzani, and D. Giustarini, “Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress,” Clinical Chemistry, vol. 52, no. 7, pp. 1406–1414, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. S. S. Sharma and K. J. Dietz, “The relationship between metal toxicity and cellular redox imbalance,” Trends in Plant Science, vol. 14, no. 1, pp. 43–50, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Liu, W. Qu, and M. B. Kadiiska, “Role of oxidative stress in cadmium toxicity and carcinogenesis,” Toxicology and Applied Pharmacology, vol. 238, no. 3, pp. 209–214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. L. N. C. Ariu, G. Morace, P. Velio, M. Campise, A. Ciani, and F. Bamonti, “Total Antioxidant Capacity (TAC) assay can be used as an environment toxicity index,” Clinical Chemistry, p. A179, 2006. View at Google Scholar